Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene transfer technologies for malignant gliomas.

A Weyerbrock1, E H Oldfield

  • 1National Institutes of Health, Surgical Neurology Branch, Bethesda, Maryland 20892-1414, USA.

Current Opinion in Oncology
|May 18, 1999
PubMed
Summary

Gene therapy for brain tumors shows promise but faces challenges in vector delivery and efficiency. Future research must focus on improved vector systems and delivery methods for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KLF6 depletion promotes NF-κB signaling in glioblastoma.

Oncogene·2017
Same author

Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine.

Journal of neuro-oncology·2015
Same author

Freiburg Neuropathology Case Conference. A Mass Lesion of the Fourth Ventricle.

Clinical neuroradiology·2015
Same author

Freiburg neuropathology case conference: tumor of the cerebellum with mild, gyriform enhancement in a 19-year-old patient.

Clinical neuroradiology·2014
Same author

[Chronic subdural hematoma as a vitally threatening mimicry of serial absence seizures].

Der Nervenarzt·2014
Same author

Freiburg neuropathology case conference: multiple small ring-enhancing lesions in a 75-year-old patient.

Clinical neuroradiology·2014

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Gene therapy

Background:

  • Early gene therapy trials for central nervous system neoplasms demonstrated proof-of-principle but fell short of preclinical expectations.
  • Key limitations include insufficient vector distribution and low transduction efficiency in human brain tumors.

Purpose of the Study:

  • To reevaluate gene transfer concepts for brain tumor treatment.
  • To identify major steps for improving gene transfer and gene therapy efficacy in malignant brain tumors.

Main Methods:

  • Designing more effective vector systems.
  • Developing novel prodrug/suicide systems, gene replacement, or immunomodulatory/anti-angiogenic strategies.
  • Investigating enhanced vector delivery and monitoring techniques for brain tumors.

Related Experiment Videos

Main Results:

  • Early trials highlighted the need for improved vector systems and delivery methods.
  • Further research is required to optimize gene transfer into the central nervous system.

Conclusions:

  • Significant advancements in vector design and delivery are crucial for successful gene therapy in brain tumors.
  • Gene therapy holds potential as part of a combined treatment approach for malignant brain tumors.